Thérèse Marie Di Paolo, PhD, is chemist with decades of research experience in neuropharmacology at Laval University, where she serves as a professor in the Faculty of Pharmacy. Her specific research expertise is on treatments for Parkinson's disease with specific interest in neuroprotective and symptomatic therapies for anti-Parkinsonian activity and antidyskinetic activity. Associated with this in vivo expertise, she has decades of experience in brain biochemical analyses of dopamine, glutamate and serotonin markers as well as neuropeptides. She publishes extensively on the effect of gonadal steroids in the brain. Moreover, she has numerous years of experience on measures of glutamate receptors in Parkinson's. She also studies behavioral effects of glutamatergic drugs and drugs of various pharmacological classes such as serotoninergic drugs, kynurenine hydroxylase inhibitor and plasmalogens.